Recommended Stocks to Buy Today, 16 June, By India’s Leading Market Experts

The Sensex Opened at 80,427.81 Against Its Previous Close of 81,691.98 and Dropped Over 1,300 points, or 1.6 per cent, to Hit an intraday low of 80,354.59, with the nifty started the day. 24,473 Against Its Previous Close of 24,888.20 and Crashed 1.7 per cent to an intraday low of 24,473.

On to the top stock picks for today, as recommended by some of India’s leading market experts.

Top three stocks recommended for today by ankush bajaj

Buy: DB Realty Ltd (Current Price: 239.93)

• Why db realty is recommended: The stock broke out of a multi-wheelk consolidation and made a new 52-wheek high with strong volume. The assessing triangle breakout on the daily chart signals further upside potential. RSI is in the mid-70s, indicating Strong Momentum. Macd remains in the bullish zone, and the stock is trading Above Key Moving Averages. The Breakout Level Around 235- 238 has now turned into support.
• Key metrics: Resistance Level: 245 (short-term target); Support level: 237 (pattern invalidation level); Pattern: Ascending Triangle Breakout; RSI: ~ 74, Indicating Strong Upward Momentum
• Technical analysis: Breakout confirmed with volume and positive macd. Price Structure Supports Further UPSide as it holds Above Prior Resistance.
• Risk Factors: With RSI Over 70, The Stock May Be Slightly Overbough, suggesting a minor pullback is possible. If price falls below 235- 237, The Breakout May Fail.
• Buy at, 239.93
• Target price, 245
• Stop Loss: 237

Also read: Escalating israel -ran conflict to keep markets on boil in near term

• Why manappuram finance is recommended: The stock continues its strong uptrend and has broken out to a new all-time high. The breakout from the recent consolidation range confirms a Continuation of the Bulish Momentum. RSI is extramely strong at 86, and macD is firmly positive. The price is trending well above all key moving average, indicating robust support from the broader trend.
• Key metrics: Resistance level: 285 (short-term target), support level: 277 (pattern invalidation level); Pattern: Horizontal Resistance Breakout / New All-Time High RSI: ~ 86, Indicating very strong bully
• Technical analysis: Strong Breakout with Price Trading Far Above Moving Average. Macd Confirms Trend Strength. Trend-Channel Formation with Bully Bulish Price Structure on Lower Time Frames.
• Risk factors: RSI is in Overbough Territory, Suggesting The Stock may consolidate or retrace in the short term. A close below 277 Cold Indicate a Failed Breakout or Temporary Top.
• Buy at, 279.54
• Target price: 285
• Stop Loss, 277

Also read: The Capital Goods Sector Gets a Power-up, its weight rises in nifty

Buy: Jubilant Ingrevia Ltd (Current Price: 793.55)

• Why Jubilant Ingrevia is recommended: The stock gave a strong bully on 13 June after forming a flag pattern on the daily chart. It surged over 16% on high volume, Confirming Strong Demand. RSI is Neering overbough levels but still rising, and the macd is positive, indicating continuing strength. Price is trading well above all key moving average. The breakout was re -rated on lower time frames and help firm, suggesting momentum is likely to continue.
• Key metrics: Resistance Level: 810 (short-term target), support level: 786 (Pattern Invalidation Level), Pattern: Bully Flag Breakout on Daily Chart, RSI: ~ 69, Rising, Showing Strengthaning Momentum.
• Technical analysis: Breakout supported by Volume, Macd Crossover, and Strong Price Action. Trading Above All Major Moving Averages. Lower time frames confirm the breakout with continued higher lows.
• Risk factors: The stock has seen a sharp move and may be overbungt in the short term, increase the chance of minor pullbacks. A drop below 786 would invalidate the breakout setup and could lead to short-term weakness.
• Buy at: 793.55
• Target price: 810
• Stop Loss: 786

Two stock recommendations by marketsmith india:

Buy: FDC Ltd. (Current Price: 475.85)

• Why FDC is recommended: Strong Domestic Brand Presence, And Focused R&D With Controlled Manufacturing
• Key metrics: P/E: 28.12, 52-wheek high: 658.85, Volume: 15.80 Crore
• Technical analysis: Gave trendline breakout
• Risk factors: Competition and Market Forces, Regulatory Environment and Pricing Pressures, ESG and Operational Risks
• Buy at: 475.85
• Target price: 550 in three months
• Stop Loss, 450

Buy: Krishna Institute of Medical Sciences Ltd (Current Price: 680)

• Why Krishna Institute of Medical Sciences is recommended: Strong Regional Presence and Brand, Capacity Expensation Through Acquisitions and Greenfield Projects
• Key metrics: P/E: 65.08, 52-wheek high: 708, Volume: 54.00 Crore
• Technical analysis: Possible trendline breakout
• Risk factors: Rising Operational Costs and Margin Pressure, Geographical Concentration
• Buy at, 680
• Target price: 800 in three months
• Stop Loss: 629

Here are three stocks to trade as recommended by raja venkatraman

Buy Maxhealth (Current Price 1232.80)

• Why maxhealth is recommended: Steady Rise Seen in this counter to the UPSIDE, as Shown on the Charts, Coupled with Steady Buying Interest at Every Decline, Has Pusted The Prices Ahead. Ahead of the results, the pris’s have pusheded beyond the media line, which spells well for the counter. The pharma sector is continuing to witness steady buying interest that is driving the trends upward. The rsi is continuing to push for more UPSIDE and Can Be Considered as a Continuation of Positive Signs of Resumption.
• Key metrics: P/E: 43.53; 52-wheek high: 98.20; Volume: 1.60 m
• Technical analysis: Support at 1125, Resistance at 1400.
• Risk factors:Regulatory Changes, Intellectual Property Issues, Competition from Generalic Drugs, Supply Chain Disrupties, and Cybersecurity Threats.
• Buy: CMP and Dips to 1210.
• Target price: 1300-1325 in 1 month.
• Stop Loss: 1195.

Buy Biocon (Current Price 355.40)

• Why biocon is recommended: This counter has managed to hold on to key support zones Around 350 and the priss quickly revised Above The Near-Term Support Zone to Head Strongly Higher in the Latter Half of the Week. We can observ Sugged more UPSIDE in the Coming Sessions.
• Key metrics: P/E: 70.04; 52-wheek high: 404.60; Volume: 8.01m
• Technical analysis: Support at 310, Resistance at 425.
• Risk factors: Regulatory Changes, Intellectual Property Issues, Competition from Generalic Drugs, Supply Chain Disrupties, and Cybersecurity Threats.
• Buy: CMP and Dips to 341.
• Target price: 385-398 in 1 month.
• Stop Loss: 332.
• Buy Star (Current Price 882.45)
• Why star is recommended: Star is showing some steady programs and the periodic higher high higher low formation is indicating that the trends are firmly hinting at some potential upside in the coming days. The Strong Long Body Candle Seen on Friday with a positive crossover
• Key metrics: P/e: 40.34; 52-wheek high: 647.65; Volume: 737.47 K
• Technical analysis: Support at 700, Resistance at 1250.
• Risk factors: Regulatory changes, intellectual property issues, competition from general drugs, supply chain disrupts, and cybersecurity threats
• Buy: CMP and Dips to 833.
• Target price, 970-1035 in 1 month.
• Stop Loss: 820.

Raja venkatraman is co-founder, neotrader. His SEBI-Registered Research Analyst registration no. is inh000016223.

Ankush bajaj is a sebi-regified research analyst. His registration number is inh000010441.

Marketsmith India is a Stock Research Platform and Advisory Service Focused on the Indian Stock Market. Trade Name: William O’neil India Pvt. Ltd; Sebi registration no.: Inh000015543

Investments in Securities are Subject to Market Risks. Read all the related documents carefully Before Investing.

Registration Granted by Sebi and Certification from Nism in No Way Guarantee Performance of the Intermediary or Provide any assuance of returns to investors.

Disclaimer: The Views and recommendations giving in this article are there that of individual analysts. These do not represent the views of Mint. We Advise Investors to Check With Certified Experts Before Making Any Investments Decisions.